ES501743A0 - Procedimiento para la obtencion de fenoxiacetatos sustitui- dos de aminas ciclicas - Google Patents

Procedimiento para la obtencion de fenoxiacetatos sustitui- dos de aminas ciclicas

Info

Publication number
ES501743A0
ES501743A0 ES501743A ES501743A ES501743A0 ES 501743 A0 ES501743 A0 ES 501743A0 ES 501743 A ES501743 A ES 501743A ES 501743 A ES501743 A ES 501743A ES 501743 A0 ES501743 A0 ES 501743A0
Authority
ES
Spain
Prior art keywords
cyclical
procedure
obtaining
phenoxyacetates
amines substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES501743A
Other languages
English (en)
Other versions
ES8202797A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of ES501743A0 publication Critical patent/ES501743A0/es
Publication of ES8202797A1 publication Critical patent/ES8202797A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES501743A 1980-04-30 1981-04-29 Procedimiento para la obtencion de fenoxiacetatos sustitui- dos de aminas ciclicas Expired ES8202797A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8009885A FR2481702A1 (fr) 1980-04-30 1980-04-30 Phenoxyacetates substitues d'amines cycliques, procede d'obtention, applications a titre de medicaments et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
ES501743A0 true ES501743A0 (es) 1982-03-01
ES8202797A1 ES8202797A1 (es) 1982-03-01

Family

ID=9241573

Family Applications (1)

Application Number Title Priority Date Filing Date
ES501743A Expired ES8202797A1 (es) 1980-04-30 1981-04-29 Procedimiento para la obtencion de fenoxiacetatos sustitui- dos de aminas ciclicas

Country Status (7)

Country Link
US (1) US4425352A (es)
EP (1) EP0039636B1 (es)
JP (1) JPS56169671A (es)
AT (1) ATE9091T1 (es)
DE (1) DE3165641D1 (es)
ES (1) ES8202797A1 (es)
FR (1) FR2481702A1 (es)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL250478A (es) 1959-04-15
GB886437A (en) * 1959-07-15 1962-01-10 Beecham Res Lab Improvements in or relating to basic esters of etherified benzilic acids
US3448110A (en) * 1966-10-03 1969-06-03 Sandoz Ag Derivatives of isobutyric acid
GB1209750A (en) * 1967-05-09 1970-10-21 Rech S Et D Applic Scient Et M Improvements in or relating to 2,2,6,6,-tetramethyl piperidine and 1,2,3,6,-tetrahydro-2,2,6,6-tetramethyl pyridine derivatives
US4233298A (en) 1969-01-31 1980-11-11 Orchimed Sa Esters of p-carbonylphenoxy-isobutyric acids
US3708587A (en) * 1970-06-08 1973-01-02 Ciba Geigy Corp Hypocholesterolemic phenoxy-aliphatic acid compositions
US3683086A (en) * 1970-07-13 1972-08-08 Sandoz Ag Derivatives of acetic acid for the alleviation of hyperlipemia
US3755417A (en) * 1971-10-04 1973-08-28 American Home Prod Tris (4-chlorophenoxy)acetic acid and esters thereof
DE2358789A1 (de) * 1973-02-07 1975-06-05 Merck Patent Gmbh Hydratropasaeure-derivate und verfahren zu ihrer herstellung
NL7416412A (nl) * 1973-12-27 1975-07-01 Siegfried Ag Werkwijze ter bereiding van nieuwe cholesterol- gende verbindingen.

Also Published As

Publication number Publication date
US4425352A (en) 1984-01-10
EP0039636A1 (fr) 1981-11-11
FR2481702A1 (fr) 1981-11-06
ATE9091T1 (de) 1984-09-15
DE3165641D1 (en) 1984-09-27
FR2481702B1 (es) 1983-05-27
EP0039636B1 (fr) 1984-08-22
ES8202797A1 (es) 1982-03-01
JPS56169671A (en) 1981-12-26

Similar Documents

Publication Publication Date Title
ES2067314T3 (es) 3-benzacepin-zonas sustituidas por un grupo benzociclobutilo o indanil-alquil-amino-alquilo, utiles en el tratamiento de las afecciones cardiovasculares.
DK0463450T3 (da) Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf
EA199900756A1 (ru) Замещенные изохинолины в качестве нервно-мышечных блокаторов ультракраткосрочного действия
SE8301608D0 (sv) /1-(2-bensoxazolyl)hydrazino/alkylnitrilderivat
GR74082B (es)
DK138982A (da) Fremgangsmaade til fremstilling af bispidinderivater
DE68910420D1 (de) Benzotriazolgruppenhaltiges Diorganopolysiloxan.
MX172953B (es) Derivados de 2-aminopirimidina-4-carboxamida, su preparacion y su aplicacion en terapeutica
DK0646578T3 (da) Phenylcarboxamidisoxazoler og deres salte, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmace
ES538339A0 (es) Procedimiento para la obtencion de o-glicosilamidas sustituidas
EP0217747A3 (en) Nematocidal agents
SE7709913L (sv) Sett att framstella penta peptider
ES501743A0 (es) Procedimiento para la obtencion de fenoxiacetatos sustitui- dos de aminas ciclicas
FI862251A (fi) Spiro-imidazolidiner som inhibitorer foer aldosreduktas.
SE7901510L (sv) Halogensubstituerade merkaptoacylaminosyror
DE3664634D1 (en) Substituted o-sulfonyl-glycosyl amides, method for their preparation and their use as mediacments
DK228086A (da) Substituerede isoxazol-derivater med antiviral virkning og fremgangsmaade af saadanne derivater
DK162095C (da) Fremgangsmaade til fremstilling af thiotetronsyre
ATE4554T1 (de) Mischungen von optischen aufhellern.
DE69001603D1 (de) Verfahren zum herstellen von perfluoroalkylbromiden.
ES509331A0 (es) Procedimiento para preparar bis- y poli-sulfuros.
ES522665A0 (es) Procedimiento para la obtencion de n-(p-sulfofenil)-cinamamida.
ES2016931B3 (es) Procedimiento de preparación de nuevas amidas alifáticas y cicloalifáticas de piridilalquilaminas o de sus derivados N-óxidos.
ES515094A0 (es) Procedimiento para preparar derivados fluorados de diaminohepteno o -heptina.
SE8205256L (sv) Tricykliska kinazolinoner